Abstract
Background and Aims Cardiometabolic disorders (CMD) arise from a constellation of features such as increased adiposity, hyperlipidemia, hypertension and compromised glucose control. Many genetic loci have shown associations with individual CMD-related traits, but no investigations have focused on simultaneously identifying loci showing associations across all domains. We therefore sought to identify loci associated with risk across seven continuous CMD-related traits.
Methods and Results We conducted separate genome-wide association studies (GWAS) for systolic and diastolic blood pressure (SBP/DBP), hemoglobin A1c (HbA1c), low- and high-density lipoprotein cholesterol (LDL-C/HDL-C), waist-to-hip-ratio (WHR), and triglycerides (TGs) in the UK Biobank (N=356,574–456,823). Multiple loci reached genome-wide levels of significance (N=145-333) for each trait, but only four loci (in/near VEGFA, GRB14-COBLL1, KLF14, and RGS19-OPRL1) were associated with risk across all seven traits (P<5×10−8). We sought replication of these four loci in an independent set of seven trait-specific GWAS meta-analyses. GRB14-COBLL1 showed the most consistent replication, revealing nominally significant associations (P<0.05) with all traits except DBP.
Conclusions Our analyses suggest that very few loci are associated in the same direction of risk with traits representing the full spectrum of CMD features. We identified four such loci, and an understanding of the pathways between these loci and CMD risk may eventually identify factors that can be used to identify pathologic disturbances that represent broadly beneficial therapeutic targets.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Heart, Lung, and Blood Institutes (R01-HL136528), and the USDA/ARS cooperative agreement # 58-3092-5-001.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involves only open available data, which can be obtained from the UK Biobank and respective genetic consortia.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Sources of Support The authors would like to acknowledge support from the National Heart, Lung, and Blood Institutes (R01-HL136528). Dr. Wood’s role on this project was funded, in part, by USDA/ARS cooperative agreement # 58-3092-5-001. The contents of this publication do not necessarily reflect the views or policies of the U.S. Department of Agriculture, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Data Availability
All data produced in the present study will be made available through the GWAS Catalog.
Abbreviations
- ALT
- alanine aminotransferase
- BMI
- body mass index
- CARDIOGRAM
- Coronary Artery Disease Genome-wide Replication And Meta-analysis
- CAD
- coronary artery disease
- CMD
- cardiometabolic disorders
- CVD
- cardiovascular disease
- DIAGRAM
- Diabetes Genetics Replication And Meta-analysis
- DBP
- diastolic blood pressure
- GERA
- Genetic Epidemiology Research on Adult Health and Aging cohort
- GIANT
- Genetic Investigation of Anthropometric Traits consortium
- GLGC
- Global Lipids Genetics Consortium
- GWAS
- genome-wide association studies
- HbA1c
- hemoglobin A1c
- HDL-C
- high-density lipoprotein cholesterol
- LDL-C
- low-density lipoprotein cholesterol
- NHANES
- National Health and Nutrition Examination Survey
- PPFC
- posterior probability of full colocalization
- SBP
- systolic blood pressure
- T2D
- type 2 diabetes
- TGs
- triglycerides
- UK
- United Kingdom
- WHR
- waist-to-hip-ratio
- WHRadjBMI
- waist-to-hip ratio adjusted for BMI